Chemopreventive compounds--view from the other side

Area of Science:

• Oncology
• Pharmacology
• Nutritional Science

Background:

• Chemopreventive agents are increasingly explored for cancer risk reduction.
• Dietary supplements often concentrate these compounds, but interactions with other food components are overlooked.
• Natural chemopreventive compounds are xenobiotics requiring rigorous safety evaluation.

Purpose of the Study:

• To highlight the limitations of current research on chemopreventive agents.
• To emphasize the need for comprehensive safety and efficacy testing of these agents.
• To address the potential adverse effects of high-dose chemopreventive compound administration.

Main Methods:

• Review of existing research on chemopreventive agents and their application in supplements.
• Analysis of the impact of in vitro simplification on predicting in vivo efficacy.
• Consideration of biotransformation processes and compound-drug interactions.

Main Results:

• Simplified in vitro models fail to account for complex metabolic interactions.
• Additive and synergistic effects of food constituents are frequently ignored.
• High-dose chemopreventive compounds may not achieve desired cancer prevention and could be detrimental.

Conclusions:

• Current approaches to chemopreventive agent research and application are insufficient.
• Thorough testing, akin to drug development, is crucial before widespread use.
• Potential risks associated with high doses and complex interactions necessitate cautious application.